Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-13 Sale | 2025-01-15 5:00 pm | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 43,804 | $1.2632 | $55,333 | 45,478 (Direct) | View |
| 2024-01-18 Sale | 2024-01-18 8:24 pm | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 5,468 | $1.1906 | $6,510 | 5,782 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-30 Option Award | 2025-01-31 5:00 pm | N/A 2035-01-29 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 562,500 | $0 | 562,500 (Direct) | View |
| 2025-01-09 Option Award | 2025-01-10 5:00 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 21,000 | $1.3 | 89,282 (Direct) | View |
| 2025-01-09 Option Award | 2025-01-10 5:00 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 62,500 | $1.36 | 89,282 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-21 4:21 pm | N/A 2034-05-19 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 462,000 | $0 | 462,000 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 5:08 pm | N/A 2034-01-11 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 96,250 | $0 | 96,250 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:19 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 375,000 | $0 | 375,000 (Direct) | View |
| 2023-01-11 Option Award | 2023-01-17 4:10 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-11 4:34 pm | N/A 2030-01-20 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-26 4:12 pm | N/A 2032-01-11 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 480,000 | $0 | 480,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-05 4:58 pm | N/A 2031-02-04 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |